Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Slowing Down Stock
919.2500 -4.90 (-0.53%)
NSE Oct 27, 2025 15:31 PM
Volume: 43,905
 

logo
Alivus Life Sciences Ltd.
16 Jul 2024
919.25
-0.53%
buy
by Hem Securities
Target: 987
Hem Securities
 
Alivus Life Sciences.. has an average target of 1317.00 from 1 broker.
More from Alivus Life Sciences Ltd.
Recommended
IPO market gains steam: Lenskart headlines this week's mainboard offerings
| 27 Oct 2025, 05:51PM
Market closes higher, Hatsun Agro's Q2 net profit rises 70% YoY
Trendlyne Marketwatch | 27 Oct 2025, 03:59PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021, 09:20AM